Response to desmopressin in type IID von Willebrand's disease. 1989

N Thomas, and U O'Callaghan, and G D Lowe, and V Olszynski, and P B Kernoff, and C F Abildgaard, and E G Tuddenham
Academic Department of Haematology, Royal Free Hospital, London, UK.

Dominant transmission of a variant of von Willebrand's disease (vWD) with aberrant polymerization of von Willebrand factor (vWF) has been identified in a Scottish family. Multimer analysis of plasma vWF from the propositus and her father revealed an identical pattern to that previously reported in families designated as type IID vWD. There is loss of the larger multimers and presence of an intermediate subsidiary band not seen in normal subjects or other vWD variants. Platelet/vWF interaction induced by ristocetin is not enhanced in these cases and the platelet vWF shows the same aberrant multimer pattern as plasma vWF. DDAVP infusion in two affected members of the Scottish family and in one of the index cases produced a rise in plasma vWF antigen and factor VIII. Higher molecular weight vWF multimers appeared transiently after infusion of desmopressin (1-deamino-8-D-arginine vasopressin, abbreviated DDAVP) coincident with shortening of the bleeding time. The platelet counts did not change after the DDAVP infusions. DDAVP should be considered for management of bleeding in this variant of von Willebrand's disease.

UI MeSH Term Description Entries
D008297 Male Males
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D003894 Deamino Arginine Vasopressin A synthetic analog of the pituitary hormone, ARGININE VASOPRESSIN. Its action is mediated by the VASOPRESSIN receptor V2. It has prolonged antidiuretic activity, but little pressor effects. It also modulates levels of circulating FACTOR VIII and VON WILLEBRAND FACTOR. Desmopressin,Vasopressin, Deamino Arginine,1-Deamino-8-D-arginine Vasopressin,1-Desamino-8-arginine Vasopressin,Adiuretin,Adiuretin SD,Apo-Desmopressin,DDAVP,Desmogalen,Desmopressin Acetate,Desmopressin Monoacetate,Desmopressin Monoacetate, Trihydrate,Desmopressine Ferring,Desmospray,Desmotabs,Minirin,Minurin,Nocutil,Octim,Octostim,Acetate, Desmopressin,Arginine Vasopressin, Deamino,Ferring, Desmopressine,Monoacetate, Desmopressin,Monoacetate, Trihydrate Desmopressin,Trihydrate Desmopressin Monoacetate,Vasopressin, 1-Deamino-8-D-arginine,Vasopressin, 1-Desamino-8-arginine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014841 von Willebrand Factor A high-molecular-weight plasma protein, produced by endothelial cells and megakaryocytes, that is part of the factor VIII/von Willebrand factor complex. The von Willebrand factor has receptors for collagen, platelets, and ristocetin activity as well as the immunologically distinct antigenic determinants. It functions in adhesion of platelets to collagen and hemostatic plug formation. The prolonged bleeding time in VON WILLEBRAND DISEASES is due to the deficiency of this factor. Factor VIII-Related Antigen,Factor VIIIR-Ag,Factor VIIIR-RCo,Plasma Factor VIII Complex,Ristocetin Cofactor,Ristocetin-Willebrand Factor,von Willebrand Protein,Factor VIII Related Antigen,Factor VIIIR Ag,Factor VIIIR RCo,Ristocetin Willebrand Factor
D014842 von Willebrand Diseases Group of hemorrhagic disorders in which the VON WILLEBRAND FACTOR is either quantitatively or qualitatively abnormal. They are usually inherited as an autosomal dominant trait though rare kindreds are autosomal recessive. Symptoms vary depending on severity and disease type but may include prolonged bleeding time, deficiency of factor VIII, and impaired platelet adhesion. Angiohemophilia,Hemophilia, Vascular,von Willebrand Disease,Vascular Pseudohemophilia,Von Willebrand Disorder,Von Willebrand's Factor Deficiency,von Willebrand Disease, Recessive Form,von Willebrand's Disease,von Willebrand's Diseases,Angiohemophilias,Disorder, Von Willebrand,Pseudohemophilia, Vascular,Pseudohemophilias, Vascular,Vascular Hemophilia,Vascular Hemophilias,Vascular Pseudohemophilias
D046911 Macromolecular Substances Compounds and molecular complexes that consist of very large numbers of atoms and are generally over 500 kDa in size. In biological systems macromolecular substances usually can be visualized using ELECTRON MICROSCOPY and are distinguished from ORGANELLES by the lack of a membrane structure. Macromolecular Complexes,Macromolecular Compounds,Macromolecular Compounds and Complexes,Complexes, Macromolecular,Compounds, Macromolecular,Substances, Macromolecular

Related Publications

N Thomas, and U O'Callaghan, and G D Lowe, and V Olszynski, and P B Kernoff, and C F Abildgaard, and E G Tuddenham
December 1984, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
N Thomas, and U O'Callaghan, and G D Lowe, and V Olszynski, and P B Kernoff, and C F Abildgaard, and E G Tuddenham
January 1990, Annales francaises d'anesthesie et de reanimation,
N Thomas, and U O'Callaghan, and G D Lowe, and V Olszynski, and P B Kernoff, and C F Abildgaard, and E G Tuddenham
August 1990, Australian and New Zealand journal of medicine,
N Thomas, and U O'Callaghan, and G D Lowe, and V Olszynski, and P B Kernoff, and C F Abildgaard, and E G Tuddenham
April 1988, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons,
N Thomas, and U O'Callaghan, and G D Lowe, and V Olszynski, and P B Kernoff, and C F Abildgaard, and E G Tuddenham
March 1991, Nederlands tijdschrift voor geneeskunde,
N Thomas, and U O'Callaghan, and G D Lowe, and V Olszynski, and P B Kernoff, and C F Abildgaard, and E G Tuddenham
April 2000, Anaesthesia and intensive care,
N Thomas, and U O'Callaghan, and G D Lowe, and V Olszynski, and P B Kernoff, and C F Abildgaard, and E G Tuddenham
November 1984, Harefuah,
N Thomas, and U O'Callaghan, and G D Lowe, and V Olszynski, and P B Kernoff, and C F Abildgaard, and E G Tuddenham
January 1997, Haemostasis,
N Thomas, and U O'Callaghan, and G D Lowe, and V Olszynski, and P B Kernoff, and C F Abildgaard, and E G Tuddenham
January 1981, Annals of internal medicine,
N Thomas, and U O'Callaghan, and G D Lowe, and V Olszynski, and P B Kernoff, and C F Abildgaard, and E G Tuddenham
March 1990, Blut,
Copied contents to your clipboard!